2024 Corporate Sustainability Performance in the Biotechnologies & Pharmaceutical sector

Please fill out the form
to download the file

This report provides a detailed analysis of the sustainability performance of 86 European companies in the Biotechnologies & Pharmaceuticals sector, based on EthiFinance’s ESG Ratings assessment conducted in 2024 with data reported for fiscal year 2023. The study highlights key trends and findings on the sector’s most material aspects across the four sustainability pillars—Environmental, Social, Governance, and External Stakeholders, offering insights into progress and challenges in sustainable practices.

Promoting informed & responsible decision-making for a more sustainable finance and economy

ESG Rating Agency

Helping investors to make informed and responsible decisions

Learn More
Credit Rating Agency

Helping companies to ensure transparency and facilitate their access to finance

Learn More
Contact Us